EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report

Shuma Hirashio iD, Sayuri Ohnari, Moe Kadono, Takeshi Shimomura, Yoshiro Tachiyama, Takao Masaki

CEN Case Reports · 20.07.2026 · 15 (4)

DOI: 10.1007/s13730-026-01164-9 ↗

Kurz gefasst

Fallbericht in der Zeitschrift CEN Case Reports, online erschienen am 20.07.2026. Verfasst von Shuma Hirashio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Otake, Hiroshima, 739‑0696, Japan. shuma.hirashio@gmail.com. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Peripheral Blood Stem Cell Transplantation. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AL amyloidosis is characterized by extracellular deposition of immunoglobulin light-chain fibrils, frequently leading to kidney involvement and progressive organ dysfunction. We report a case of kidney AL amyloidosis secondary to multiple myeloma in which daratumumab-based chemotherapy combined with autologous peripheral blood stem cell transplantation resulted in marked improvement, as confirmed by sequential kidney biopsy. The initial biopsy revealed vascular-dominant amyloid deposition, whereas the second biopsy obtained 2 years later demonstrated a marked reduction in amyloid burden, particularly within the vascular compartments. This histopathological improvement corresponded with hematologic remission and stabilization of kidney function. The observed reduction in tissue amyloid deposits was presumed to result from suppression of amyloidogenic light chains, leading to inhibition of new fibril formation and subsequent tissue remodeling. Our findings provide direct pathological evidence that daratumumab-based combination therapy, through immune-mediated plasma cell depletion, may indirectly promote the regression of amyloid deposits and contribute to functional recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalImmunoglobulin Light-chain AmyloidosisMultiple MyelomaPeripheral Blood Stem Cell TransplantationHumansMaleAmyloidBiopsyImmunoglobulin Light ChainsKidneyTransplantation, AutologousTreatment OutcomeAged

Stichwörter der Autor:innen

Amyloid regressionAmyloidosisAutologous peripheral blood stem cell transplantationCase reportDaratumumabKidney biopsy

Substanzen

AmyloidAntibodies, MonoclonaldaratumumabImmunoglobulin Light Chains

Autor:innen und Institutionen

  • Department of Nephrology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Otake, Hiroshima, 739‑0696, Japan. shuma.hirashio@gmail.com.
  • Department of Nephrology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan. shuma.hirashio@gmail.com.
  • Department of Nephrology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Otake, Hiroshima, 739‑0696, Japan.
  • Department of Hematology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Ootake, Hiroshima, 739‑0696, Japan.
  • Department of Diagnostic Pathology, NHO Hiroshimanishi Medical Center, 4‑1‑1 Kuba, Ootake, Hiroshima, 739‑0696, Japan.
  • Department of Nephrology, Hiroshima University Hospital, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

ORCID-Profile: Shuma Hirashio

Zitieren

APA

Hirashio, S., Ohnari, S., Kadono, M., Shimomura, T., Tachiyama, Y., & Masaki, T. (2026). Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report. CEN Case Reports, 15(4). https://doi.org/10.1007/s13730-026-01164-9

Vancouver

Hirashio S, Ohnari S, Kadono M, Shimomura T, Tachiyama Y, Masaki T. Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report. CEN Case Reports. 2026;15(4). doi:10.1007/s13730-026-01164-9

BibTeX
@article{Hirashio2026,
  author = {Hirashio, Shuma and Ohnari, Sayuri and Kadono, Moe and Shimomura, Takeshi and Tachiyama, Yoshiro and Masaki, Takao},
  title = {Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report},
  journal = {CEN Case Reports},
  year = {2026},
  volume = {15},
  number = {4},
  doi = {10.1007/s13730-026-01164-9}
}
Kostenlos starten →